QQ客服 官方微博 反馈留言

	First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers
	Fan, Ying; Li, Shu; Ding, Xiaoyan; Yue, Jian; Jiang, Jun; Zhao, Hong; Hao, Rui; Qiu, Weiliang; Liu, Kezhen; Li, Ying
	2019
卷号	19期号:1页码:279
关键词	Small molecule immune modulation Phase I trial in advanced hepatocellular carcinoma
ISSN号	1471-2407
DOI	10.1186/s12885-019-5471-1
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6343184
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Fan, Ying,Li, Shu,Ding, Xiaoyan,et al. First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers[J],2019,19(1):279.
APA	Fan, Ying.,Li, Shu.,Ding, Xiaoyan.,Yue, Jian.,Jiang, Jun.,...&Xu, Binghe.(2019).First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers.,19(1),279.
MLA	Fan, Ying,et al."First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers".19.1(2019):279.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。